Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Hospitals
  4. /Healthcare Global Enterprises Ltd
MomentumDeep Value

Healthcare Global Enterprises Ltd: Stock Analysis & Fundamentals

Updated this week

Healthcare Global Enterprises Ltd (Hospitals) — fundamental analysis, earnings data, and key metrics. PE: 292.0. ROE: 5.1%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

👔Promoter stake down 7.5% this quarter
🌐FII stake decreased 0.7% this quarter
🏛️DII accumulation — stake up 6.7%

Key Numbers

Current Price
₹532
Market Cap
7.9K Cr
Valuation
N/A

Other Top Hospitals Stocks Beating Nifty 500

Apollo Hospitals Enterprise Ltd
Average • 6w streak
+17.1%
Aster DM Healthcare Ltd
Weak • 4w streak
+19.7%
KMC Speciality Hospitals (India) Ltd
Average • 12w streak
+15.5%
Sakar Healthcare Ltd
Average • 11w streak
+34.0%
← Back to HospitalsDashboard

Frequently Asked Questions: Healthcare Global Enterprises Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Healthcare Global Enterprises Ltd's latest quarterly results?

Healthcare Global Enterprises Ltd's latest quarterly results (Dec 2025) show

  • PAT Growth YoY: -201.9%
  • Revenue Growth YoY: +13.3%
  • Operating Margin: 17.3%

What is Healthcare Global Enterprises Ltd's current PE ratio?

Healthcare Global Enterprises Ltd's current PE ratio is 292.0x.

  • Current PE: 292.0x
  • Market Cap: 7.9K Cr

What is Healthcare Global Enterprises Ltd's price-to-book ratio?

Healthcare Global Enterprises Ltd's price-to-book ratio is 8.6x.

  • Price-to-Book (P/B): 8.6x
  • Book Value per Share: ₹62
  • Current Price: ₹532

Is Healthcare Global Enterprises Ltd a fundamentally strong company?

Healthcare Global Enterprises Ltd's fundamental strength based on key financial ratios

  • Return on Capital (ROCE): 9.0%

Is Healthcare Global Enterprises Ltd debt free?

Healthcare Global Enterprises Ltd has a debt-to-equity ratio of N/A.

  • Total Debt: ₹2,000 Cr

What is Healthcare Global Enterprises Ltd's return on equity (ROE) and ROCE?

Healthcare Global Enterprises Ltd's return ratios over recent years

  • FY2023: ROCE 8.0%
  • FY2024: ROCE 9.0%
  • FY2025: ROCE 9.0%

Is Healthcare Global Enterprises Ltd's cash flow positive?

Healthcare Global Enterprises Ltd's operating cash flow is positive (FY2025).

  • Cash from Operations (CFO): ₹317 Cr
  • Free Cash Flow (FCF): ₹-171 Cr
  • CFO/PAT Ratio: 647% (strong cash conversion)

What is Healthcare Global Enterprises Ltd's dividend yield?

Healthcare Global Enterprises Ltd currently does not pay a significant dividend (yield 0.00%).

  • Dividend Yield: 0.00%
  • Current Price: ₹532

Who holds Healthcare Global Enterprises Ltd shares — promoters, FII, DII?

Healthcare Global Enterprises Ltd's shareholding pattern (Dec 2025)

  • Promoters: 63.8%
  • FII (Foreign): 3.2%
  • DII (Domestic): 18.3%
  • Public: 14.7%

Is promoter holding increasing or decreasing in Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd's promoter holding has decreased recently.

  • Current Promoter Holding: 63.8% (Dec 2025)
  • Previous Quarter: 63.8% (Sep 2025)
  • Change: -0.01% (decreasing — worth monitoring)

Is Healthcare Global Enterprises Ltd a new momentum entry or an established outperformer?

Healthcare Global Enterprises Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Healthcare Global Enterprises Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Healthcare Global Enterprises Ltd may be worth studying

  • Cash flow is positive — CFO ₹317 Cr

What is the investment thesis for Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd investment thesis summary:

What is the future outlook for Healthcare Global Enterprises Ltd?

Healthcare Global Enterprises Ltd's forward outlook based on current data signals

  • Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.